{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T20:03:00Z","timestamp":1781208180400,"version":"3.54.1"},"reference-count":40,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2018,2,12]],"date-time":"2018-02-12T00:00:00Z","timestamp":1518393600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Proteomes"],"abstract":"<jats:p>Targeting of leukemic stem cells with specific immunotherapy would be an ideal approach for the treatment of myeloid malignancies, but suitable epitopes are unknown. The comparative proteome-level characterization of hematopoietic stem and progenitor cells from healthy stem cell donors and patients with acute myeloid leukemia has the potential to reveal differentially expressed proteins which can be used as surface-markers or as proxies for affected molecular pathways. We employed mass spectrometry methods to analyze the proteome of the cytosolic and the membrane fraction of CD34 and CD123 co-expressing FACS-sorted leukemic progenitors from five patients with acute myeloid leukemia. As a reference, CD34+CD123+ normal hematopoietic progenitor cells from five healthy, granulocyte-colony stimulating factor (G-CSF) mobilized stem cell donors were analyzed. In this Tandem Mass Tag (TMT) 10-plex labelling\u2013based approach, 2070 proteins were identified with 171 proteins differentially abundant in one or both cellular compartments. This proof-of-principle-study demonstrates the potential of mass spectrometry to detect differentially expressed proteins in two compartment fractions of the entire proteome of leukemic stem cells, compared to their non-malignant counterparts. This may contribute to future immunotherapeutic target discoveries and individualized AML patient characterization.<\/jats:p>","DOI":"10.3390\/proteomes6010011","type":"journal-article","created":{"date-parts":[[2018,2,12]],"date-time":"2018-02-12T12:28:03Z","timestamp":1518438483000},"page":"11","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Pilot Study on Mass Spectrometry\u2013Based Analysis of the Proteome of CD34+CD123+ Progenitor Cells for the Identification of Potential Targets for Immunotherapy in Acute Myeloid Leukemia"],"prefix":"10.3390","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2026-9715","authenticated-orcid":false,"given":"Johannes","family":"Schmidt","sequence":"first","affiliation":[{"name":"Department of Molecular Systems Biology, Helmholtz-Centre for Environmental Research\u2014UFZ, 04318 Leipzig, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elke","family":"R\u00fccker-Braun","sequence":"additional","affiliation":[{"name":"Department of Medicine I, University Hospital of Dresden, 01307 Dresden, Germany"},{"name":"Center for Regenerative Therapies Dresden, TU Dresden, 01307 Dresden, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharina","family":"Heidrich","sequence":"additional","affiliation":[{"name":"Department of Medicine I, University Hospital of Dresden, 01307 Dresden, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malte","family":"Von Bonin","sequence":"additional","affiliation":[{"name":"Department of Medicine I, University Hospital of Dresden, 01307 Dresden, Germany"},{"name":"German Cancer Consortium (DKTK), 01307 Dresden, Germany"},{"name":"German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Friedrich","family":"St\u00f6lzel","sequence":"additional","affiliation":[{"name":"Department of Medicine I, University Hospital of Dresden, 01307 Dresden, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Thiede","sequence":"additional","affiliation":[{"name":"Department of Medicine I, University Hospital of Dresden, 01307 Dresden, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3250-293X","authenticated-orcid":false,"given":"Jan","family":"Middeke","sequence":"additional","affiliation":[{"name":"Department of Medicine I, University Hospital of Dresden, 01307 Dresden, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerhard","family":"Ehninger","sequence":"additional","affiliation":[{"name":"Department of Medicine I, University Hospital of Dresden, 01307 Dresden, Germany"},{"name":"Center for Regenerative Therapies Dresden, TU Dresden, 01307 Dresden, Germany"},{"name":"German Cancer Consortium (DKTK), 01307 Dresden, Germany"},{"name":"German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany"},{"name":"National Center for Tumor Diseases, University Hospital Carl Gustav Carus, TU Dresden, 01307 Dresden, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Bornh\u00e4user","sequence":"additional","affiliation":[{"name":"Department of Medicine I, University Hospital of Dresden, 01307 Dresden, Germany"},{"name":"Center for Regenerative Therapies Dresden, TU Dresden, 01307 Dresden, Germany"},{"name":"German Cancer Consortium (DKTK), 01307 Dresden, Germany"},{"name":"German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany"},{"name":"National Center for Tumor Diseases, University Hospital Carl Gustav Carus, TU Dresden, 01307 Dresden, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2780-2981","authenticated-orcid":false,"given":"Johannes","family":"Schetelig","sequence":"additional","affiliation":[{"name":"Department of Medicine I, University Hospital of Dresden, 01307 Dresden, Germany"},{"name":"DKMS German Bone Marrow Donor Center, Clinical Trials Unit, 01309 Dresden, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristin","family":"Schubert","sequence":"additional","affiliation":[{"name":"Department of Molecular Systems Biology, Helmholtz-Centre for Environmental Research\u2014UFZ, 04318 Leipzig, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Von Bergen","sequence":"additional","affiliation":[{"name":"Department of Molecular Systems Biology, Helmholtz-Centre for Environmental Research\u2014UFZ, 04318 Leipzig, Germany"},{"name":"Institute of Biochemistry, Faculty of Life Sciences, Leipzig University, 04103 Leipzig, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Falk","family":"Heidenreich","sequence":"additional","affiliation":[{"name":"Department of Medicine I, University Hospital of Dresden, 01307 Dresden, Germany"},{"name":"DKMS German Bone Marrow Donor Center, Clinical Trials Unit, 01309 Dresden, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2018,2,12]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"5720","DOI":"10.1038\/sj.onc.1206855","article-title":"Proteomic analysis of hematopoietic stem cell-like fractions in leukemic disorders","volume":"22","author":"Ota","year":"2003","journal-title":"Oncogene"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"5734","DOI":"10.1016\/j.jprot.2012.07.030","article-title":"Comparative proteome analysis of acute myeloid leukemia with and without maturation","volume":"75","author":"Luczak","year":"2012","journal-title":"J. Proteom."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1074\/mcp.M112.021931","article-title":"A proteomics and transcriptomics approach to identify leukemic stem cell (LSC) markers","volume":"12","author":"Bonardi","year":"2013","journal-title":"Mol. Cell. Proteom."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.jprot.2014.01.022","article-title":"A comprehensive surface proteome analysis of myeloid leukemia cell lines for therapeutic antibody development","volume":"99","author":"Strassberger","year":"2014","journal-title":"J. Proteom."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1002\/pmic.201300448","article-title":"Performance of super-SILAC based quantitative proteomics for comparison of different acute myeloid leukemia (AML) cell lines","volume":"14","author":"Vaudel","year":"2014","journal-title":"Proteomics"},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Hofmann, A., Gerrits, B., Schmidt, A., Bock, T., Bausch-Fluck, D., Aebersold, R., and Wollscheid, B. (2010). Proteomic cell surface phenotyping of differentiating acute myeloid leukemia cells. Blood, 116.","DOI":"10.1182\/blood-2010-02-271270"},{"key":"ref_7","first-page":"52","article-title":"Global Cell Proteome Profiling, Phospho-signaling and Quantitative Proteomics for Identification of New Biomarkers in Acute Myeloid Leukemia Patients","volume":"17","author":"Forthun","year":"2016","journal-title":"Curr. Pharm. Biotechnol."},{"key":"ref_8","first-page":"95","article-title":"Comparative proteomics in acute myeloid leukemia","volume":"16","author":"Luczak","year":"2012","journal-title":"Contemp. Oncol. (Pozn. Pol.)"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1038\/sj.leu.2401903","article-title":"The interleukin-3 receptor alpha chain is a unique marker for human acute myelogenous leukemia stem cells","volume":"14","author":"Jordan","year":"2000","journal-title":"Leukemia"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.stem.2009.04.018","article-title":"Monoclonal Antibody-Mediated Targeting of CD123, IL-3 Receptor \u03b1 Chain, Eliminates Human Acute Myeloid Leukemic Stem Cells","volume":"5","author":"Jin","year":"2009","journal-title":"Cell Stem Cell"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s13045-016-0292-z","article-title":"Immunoprofiling of leukemic stem cells CD34+\/CD38\u2212\/CD123+ delineate FLT3\/ITD-positive clones","volume":"9","author":"Gillis","year":"2016","journal-title":"J. Hematol. Oncol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"20","DOI":"10.15379\/2408-9877.2014.01.01.4","article-title":"Changes in the Cell Surface Markers During Normal Hematopoiesis: A Guide to Cell Isolation","volume":"1","author":"Attar","year":"2014","journal-title":"Glob. J. Hematol. Blood Transfus."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"4086","DOI":"10.1182\/blood-2005-03-1072","article-title":"Hematopoietic stem cells express multiple myeloid markers: Implications for the origin and targeted therapy of acute myeloid leukemia","volume":"106","author":"Taussig","year":"2005","journal-title":"Blood"},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Jouy, F., Lohmann, N., Wandel, E., Ruiz-G\u00f3mez, G., Pisabarro, M.T., Beck-Sickinger, A.G., Schnabelrauch, M., M\u00f6ller, S., Simon, J.C., and Kalkhof, S. (2017). Sulfated hyaluronan attenuates inflammatory signaling pathways in macrophages involving induction of antioxidants. Proteomics, 17.","DOI":"10.1002\/pmic.201700082"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"D447","DOI":"10.1093\/nar\/gkv1145","article-title":"2016 update of the PRIDE database and its related tools","volume":"44","author":"Csordas","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/nprot.2008.211","article-title":"Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources","volume":"4","author":"Huang","year":"2009","journal-title":"Nat. Protoc."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1093\/bioinformatics\/btt703","article-title":"Causal analysis approaches in Ingenuity Pathway Analysis","volume":"30","author":"Green","year":"2014","journal-title":"Bioinformatics"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1159\/000480448","article-title":"CD34+CD38\u2212CD123+ Cells Are Present in Virtually All Acute Myeloid Leukaemia Blasts: A Promising Single Unique Phenotype for Minimal Residual Disease Detection","volume":"138","author":"Pinto","year":"2017","journal-title":"Acta Haematol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"e218","DOI":"10.1038\/bcj.2014.39","article-title":"Distribution and levels of cell surface expression of CD33 and CD123 in acute myeloid leukemia","volume":"4","author":"Ehninger","year":"2014","journal-title":"Blood Cancer J."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1002\/stem.170265","article-title":"Correlation between IL-3 receptor expression and growth potential of human CD34+ hematopoietic cells from different tissues","volume":"17","author":"Huang","year":"1999","journal-title":"Stem Cells"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1038\/sj.leu.2401493","article-title":"Signal transduction, cell cycle regulatory, and anti-apoptotic pathways regulated by IL-3 in hematopoietic cells: Possible sites for intervention with anti-neoplastic drugs","volume":"13","author":"Blalock","year":"1999","journal-title":"Leukemia"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/2050-7771-2-4","article-title":"CD 123 is a membrane biomarker and a therapeutic target in hematologic malignancies","volume":"2","author":"Testa","year":"2014","journal-title":"Biomark. Res."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1186\/s13045-017-0505-0","article-title":"Recent developments in immunotherapy of acute myeloid leukemia","volume":"10","author":"Lichtenegger","year":"2017","journal-title":"J. Hematol. Oncol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1177\/2040620715616544","article-title":"Novel immunotherapeutic approaches for the treatment of acute leukemia (myeloid and lymphoblastic)","volume":"7","author":"Ishii","year":"2016","journal-title":"Ther. Adv. Hematol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/j.bbrc.2007.03.191","article-title":"Comparative analysis of cell surface proteins in chronic and acute leukemia cell lines","volume":"357","author":"Lee","year":"2007","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_26","first-page":"135","article-title":"Cell fractionation\u2014An important tool for compartment proteomics","volume":"1","author":"Rockstroh","year":"2011","journal-title":"Jiomics"},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Hernandez-Valladares, M., Aaseb\u00f8, E., Selheim, F., Berven, F.S., and Bruserud, \u00d8. (2016). Selecting Sample Preparation Workflows for Mass Spectrometry-Based Proteomic and Phosphoproteomic Analysis of Patient Samples with Acute Myeloid Leukemia. Proteomes.","DOI":"10.3390\/proteomes4030024"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1056\/NEJMoa1609279","article-title":"T-Cell Transfer Therapy Targeting Mutant KRAS in Cancer","volume":"375","author":"Tran","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1038\/leu.2014.233","article-title":"Mapping the HLA ligandome landscape of acute myeloid leukemia: a targeted approach toward peptide-based immunotherapy","volume":"29","author":"Berlin","year":"2015","journal-title":"Leukemia"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1007\/s00432-002-0413-7","article-title":"Cloning and functional characterization of GMPR2, a novel human guanosine monophosphate reductase, which promotes the monocytic differentiation of HL-60 leukemia cells","volume":"129","author":"Zhang","year":"2003","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1182\/blood-2017-02-768762","article-title":"AML-specific cytotoxic antibodies in patients with durable graft-versus-leukemia responses","volume":"131","author":"Gillissen","year":"2018","journal-title":"Blood"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"32532","DOI":"10.18632\/oncotarget.8687","article-title":"Phase I clinical study of RG7356, an anti-CD44 humanized antibody, in patients with acute myeloid leukemia","volume":"7","author":"Vey","year":"2016","journal-title":"Oncotarget"},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Chung, S.S., Eng, W.S., Hu, W., Khalaj, M., Garrett-Bakelman, F.E., Tavakkoli, M., Levine, R.L., Carroll, M., Klimek, V.M., and Melnick, A.M. (2017). CD99 is a therapeutic target on disease stem cells in myeloid malignancies. Sci. Transl. Med., 9.","DOI":"10.1126\/scitranslmed.aaj2025"},{"key":"ref_34","first-page":"1497","article-title":"Effects of interleukin-13 on cytokine secretion by human acute myelogenous leukemia blasts","volume":"10","author":"Bruserud","year":"1996","journal-title":"Leukemia"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"4251","DOI":"10.1182\/blood-2010-01-262071","article-title":"Recurrent expression signatures of cytokines and chemokines are present and are independently prognostic in acute myelogenous leukemia and myelodysplasia","volume":"116","author":"Kornblau","year":"2010","journal-title":"Blood"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"2597","DOI":"10.1182\/blood-2007-06-093237","article-title":"Cross-talk between RhoH and Rac1 in regulation of actin cytoskeleton and chemotaxis of hematopoietic progenitor cells","volume":"111","author":"Chae","year":"2008","journal-title":"Blood"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1182\/blood-2004-04-1604","article-title":"RhoH, a hematopoietic-specific Rho GTPase, regulates proliferation, survival, migration, and engraftment of hematopoietic progenitor cells","volume":"105","author":"Gu","year":"2005","journal-title":"Blood"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.cca.2012.12.012","article-title":"ACTB in cancer","volume":"417","author":"Guo","year":"2013","journal-title":"Clin. Chim. Acta"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1093\/carcin\/bgv016","article-title":"PU.1 downregulation in murine radiation-induced acute myeloid leukaemia (AML): From molecular mechanism to human AML","volume":"36","author":"Verbiest","year":"2014","journal-title":"Carcinogenesis"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1080\/14789450.2017.1352474","article-title":"Proteogenomics approaches for studying cancer biology and their potential in the identification of acute myeloid leukemia biomarkers","volume":"14","author":"Vaudel","year":"2017","journal-title":"Expert Rev. Proteom."}],"container-title":["Proteomes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2227-7382\/6\/1\/11\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T14:54:50Z","timestamp":1760194490000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2227-7382\/6\/1\/11"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,12]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,3]]}},"alternative-id":["proteomes6010011"],"URL":"https:\/\/doi.org\/10.3390\/proteomes6010011","relation":{},"ISSN":["2227-7382"],"issn-type":[{"value":"2227-7382","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,12]]}}}